Pier Capital’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-262,832
| Closed | -$1.65M | – | 108 |
|
|
2022
Q4 | $1.65M | Sell |
262,832
-748
| -0.3% | -$4.71K | 0.27% | 93 |
|
|
2022
Q3 | $2.85M | Sell |
263,580
-476,976
| -64% | -$5.15M | 0.49% | 85 |
|
|
2022
Q2 | $8.44M | Sell |
740,556
-6,113
| -0.8% | -$69.7K | 1.44% | 18 |
|
|
2022
Q1 | $6.8M | Buy |
746,669
+451,701
| +153% | +$4.11M | 0.87% | 68 |
|
|
2021
Q4 | $4.4M | Sell |
294,968
-155,214
| -34% | -$2.32M | 0.46% | 93 |
|
|
2021
Q3 | $11.6M | Buy |
450,182
+171,354
| +61% | +$4.4M | 1.2% | 34 |
|
|
2021
Q2 | $7.27M | Buy |
278,828
+5,182
| +2% | +$135K | 0.73% | 83 |
|
|
2021
Q1 | $9.66M | Buy |
273,646
+121,575
| +80% | +$4.29M | 0.92% | 70 |
|
|
2020
Q4 | $3.84M | Buy |
152,071
+3,843
| +3% | +$97K | 0.41% | 98 |
|
|
2020
Q3 | $5.59M | Buy |
+148,228
| New | +$5.59M | 0.82% | 77 |
|